Clinical Trial Logistics
Clinical trial logistics ensures that investigational products reach patients on time, in full, and in the correct condition. For drug developers and CROs, it is one of the most operationally sensitive parts of running a study – and often where delays, bottlenecks and hidden risks surface.
Why Clinical Trial Logistics matters
Reliable logistics directly shapes patient safety, study timelines and data quality. A delayed shipment can postpone a patient visit. A temperature excursion can invalidate product. A customs error can block activation of an entire country. As trials become more global and protocols more complex, logistics performance increasingly acts as a differentiator rather than a background function.
A strong logistics setup protects:
- Timelines – enabling on-time site activation and uninterrupted patient dosing
- Product integrity – maintaining temperature, chain of custody and compliance
- Cost and waste – through accurate forecasting and efficient distribution
How Clinical Trial Logistics Works in Practice
Supply Planning
Operational teams translate protocol assumptions into demand models—taking into account dosing schedules, product shelf life, anticipated enrolment curves and country activation sequences. Planning is iterative, not static, because real recruitment rarely matches forecasts.
Distribution Strategy
Sponsors choose between global, regional or local depot structures. Decisions depend on product sensitivity, lead times, regulatory requirements and cost. Biologics, cell therapies and short-shelf-life products often require decentralised and temperature-controlled networks. Selection of the optimum distribution strategy for a clinical trial is a topic in itself, and will be covered separately in a future paper.
Site Execution
Sites must receive the right quantity of drug, at the right time, in the right condition. The operational reality includes goods receipt, temperature monitoring, managing accountability logs, recording deviations, processing returns and coordinating restock.
Key Decision Areas
Depot Model
| Option | When it works | Risk |
| Single global depot | Centralized control, small trials, simple trials, rare diseases | Long lead times, customs risk |
| Regional depots | Global trials with temperature sensitive products | Higher cost |
| Local depots | Markets with strict regulatory and customs requirements, treatments for acute conditions where rapid delivery is essential | Complex to coordinate |
Courier and Transport Strategy
Courier capability heavily influences reliability—especially for cold chain and routes involving customs complexity. For a deeper breakdown, see the dedicated solution page: Courier Selection for Clinical Trials.
The Outcome
A well-designed logistics strategy prevents disruptions, reduces waste and safeguards patient dosing. As studies scale globally and product modalities become more complex, logistics maturity becomes a competitive advantage—enabling teams to stay ahead of risk, maintain control.
At KLIFO we can help design your clinical trial logistic strategy.
We know how important a smooth distribution setup is for clinical trials and our support spans from manufacturing through to patient dosing. Our highly experienced team combines strategic insight with operational excellence to ensure that our clients’ investigational products reach clinical trial sites safely, on time and in perfect condition. We work proactively work with our clients to identify risks and mitigate against these, delivering peace of mind when stakes are high.
Are you interested in knowing more about how we can support your clinical trial distribution?
